Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

4TQH

Human transthyretin (TTR) complexed with 3-(9H-fluoren-9-ylideneaminooxy)ethanoic acid

4TQH の概要
エントリーDOI10.2210/pdb4tqh/pdb
関連するPDBエントリー3GS0 3GS4 4TQ8 4TQI 4TQP
分子名称Transthyretin, [(9H-fluoren-9-ylideneamino)oxy]acetic acid, 1,2-ETHANEDIOL, ... (4 entities in total)
機能のキーワードtransthyretin (ttr) complex, amyloid antagonist and inhibitor, fluorenone based inhibitor, dual binding mode, hormone
由来する生物種Homo sapiens (Human)
細胞内の位置Secreted: P02766
タンパク質・核酸の鎖数2
化学式量合計28123.29
構造登録者
Ciccone, L.,Nencetti, S.,Rossello, A.,Orlandini, E.,Stura, E.A. (登録日: 2014-06-11, 公開日: 2015-06-24, 最終更新日: 2023-09-27)
主引用文献Ciccone, L.,Nencetti, S.,Rossello, A.,Tepshi, L.,Stura, E.A.,Orlandini, E.
X-ray crystal structure and activity of fluorenyl-based compounds as transthyretin fibrillogenesis inhibitors.
J Enzyme Inhib Med Chem, :1-10, 2015
Cited by
PubMed Abstract: Transthyretin (TTR) is a 54 kDa homotetrameric protein that transports thyroxine (T4) and retinol (vitamin A), through its association with retinol binding protein (RBP). Under unknown conditions, it aggregates to form fibrils associated with TTR amyloidosis. Ligands able to inhibit fibril formation have been studied by X-ray crystallography. The use of polyethylene glycol (PEG) instead of ammonium sulphate or citrate has been evaluated as an alternative to obtain new TTR complexes with (R)-3-(9-fluoren-9-ylideneaminooxy)-2-methyl-N-(methylsulfonyl) propionamide (48R(1)) and 2-(9H-fluoren-9-ylideneaminooxy) acetic acid (ES8(2)). The previously described fluorenyl based inhibitors (S)-3-((9H-fluoren-9-ylideneamino)oxy)-2-methylpropanoic acid (6BD) and 3-((9H-fluoren-9-ylideneamino)oxy)propanoic acid (7BD) have been re-evaluated with the changed crystallization method. The new TTR complexes with compounds of the same family show that the 9-fluorenyl motif can occupy alternative hydrophobic binding sites. This augments the potential use of this scaffold to yield a large variety of differently substituted mono-aryl compounds able to inhibit TTR fibril formation.
PubMed: 26235916
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (1.511 Å)
構造検証レポート
Validation report summary of 4tqh
検証レポート(詳細版)ダウンロードをダウンロード

252456

件を2026-04-22に公開中

PDB statisticsPDBj update infoContact PDBjnumon